CRSP CRISPR Therapeutics AG PE ratio, current and historical analysis
The current PE ratio of CRSP can't be determined, as the TTM EPS of -$2.8 is negative. The last PE ratio of CRISPR Therapeutics AG, recorded in March 2022, was 15.16.
CRSP PE ratio history
The PE ratio of CRISPR Therapeutics AG has averaged 34.33 over the last eight years. In the past eight years, CRSP's PE ratio peaked in the Jun 2020 quarter at 118.53, when the stock price was $73.49 and the EPS was $0.62. The lowest point was in the Sep 2017 quarter, when it reached 4.68 with a price of $17.87 and an EPS of $3.82.
CRISPR Therapeutics AG PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 15.25 | N/A |
| 2020 | N/A | N/A |
| 2019 | 49.52 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
CRSP average PE ratio chart
CRSP PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 21 | $93.12M |
| OLMA Olema Pharmaceuticals Inc | N/A | $450.93M |
| OMER Omeros Corp | N/A | $447.95M |
| OMGA Omega Therapeutics Inc | N/A | $42.96M |
| ONCT Oncternal Therapeutics Inc | N/A | $3.43M |
| ONVO Organovo Holdings Inc | N/A | $5.38M |
| ORIC Oric Pharmaceuticals Inc | N/A | $643.57M |
| CRSP CRISPR Therapeutics AG | N/A | $3.95B |
Frequently asked questions
What is CRISPR Therapeutics AG's PE ratio?
The current price to earnings ratio of CRSP can't be calculated, as its EPS of -$2.8 is negative.
What is the 5-year average PE ratio for CRISPR Therapeutics AG (CRSP)?
Over the last 5 years, the average price to earnings ratio for CRSP stock is 42.11.
What is the highest PE ratio for CRSP?
In the last eight years, the Jun 2020 quarter recorded the highest quarterly PE ratio at 118.53.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.